| The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial START Trialists' Group The Lancet 371 (9618), 1098-1107, 2008 | 1469 | 2008 |
| A measure of interpersonal dependency RMA Hirschfeld, GL Klerman, HG Gouch, J Barrett, SJ Korchin, P Chodoff Journal of personality assessment 41 (6), 610-618, 1977 | 952 | 1977 |
| The prevalence of psychiatric disorders in a primary care practice JE Barrett, JA Barrett, TE Oxman, PD Gerber Archives of general psychiatry 45 (12), 1100-1106, 1988 | 791 | 1988 |
| COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study LYW Lee, JB Cazier, T Starkey, SEW Briggs, R Arnold, V Bisht, S Booth, ... The Lancet Oncology 21 (10), 1309-1316, 2020 | 628 | 2020 |
| Treatment of dysthymia and minor depression in primary care: a randomized controlled trial in older adults JW Williams Jr, J Barrett, T Oxman, E Frank, W Katon, M Sullivan, ... Jama 284 (12), 1519-1526, 2000 | 599 | 2000 |
| Social support and depressive symptoms in the elderly TE Oxman, LF Berkman, S Kasl, DH Freeman Jr, J Barrett American journal of epidemiology 135 (4), 356-368, 1992 | 529 | 1992 |
| There’s an app for that: content analysis of paid health and fitness apps JH West, PC Hall, CL Hanson, MD Barnes, C Giraud-Carrier, J Barrett Journal of medical Internet research 14 (3), e72, 2012 | 425 | 2012 |
| The King-Devick test as a determinant of head trauma and concussion in boxers and MMA fighters KM Galetta, J Barrett, M Allen, F Madda, D Delicata, AT Tennant, ... Neurology 76 (17), 1456-1462, 2011 | 379 | 2011 |
| Peptide toxins from Conus geographus venom. WR Gray, A Luque, BM Olivera, J Barrett, LJ Cruz Journal of Biological Chemistry 256 (10), 4734-4740, 1981 | 360 | 1981 |
| Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors M Schütte, T Risch, N Abdavi-Azar, K Boehnke, D Schumacher, M Keil, ... Nature communications 8 (1), 14262, 2017 | 305 | 2017 |
| Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: implications for depressive disorders and future therapies X Khawaja, J Xu, JJ Liang, JE Barrett Journal of neuroscience research 75 (4), 451-460, 2004 | 267 | 2004 |
| Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study JC Glasbey, D Nepogodiev, JFF Simoes, O Omar, E Li, ML Venn, PGDME, ... Journal of Clinical Oncology 39 (1), 66-78, 2021 | 261 | 2021 |
| Hippocampal expression analyses reveal selective association of immediate-early, neuroenergetic, and myelinogenic pathways with cognitive impairment in aged rats WB Rowe, EM Blalock, KC Chen, I Kadish, D Wang, JE Barrett, O Thibault, ... Journal of Neuroscience 27 (12), 3098-3110, 2007 | 244 | 2007 |
| The relationship of presenting physical complaints to depressive symptoms in primary care patients PD Gerber, JE Barrett, JA Barrett, TE Oxman, E Manheimer, R Smith, ... Journal of General Internal Medicine 7, 170-173, 1992 | 215 | 1992 |
| Recognition of depression by internists in primary care: a comparison of internist and “gold standard” psychiatric assessments PD Gerber, J Barrett, J Barrett, E Manheimer, R Whiting, R Smith Journal of General Internal Medicine 4 (1), 7-13, 1989 | 208 | 1989 |
| Development and validation of the SDDS-PC screen for multiple mental disorders in primary care WE Broadhead, AC Leon, MM Weissman, JE Barrett, RS Blacklow, ... | 206 | 1995 |
| 5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions JE Barrett, KE Vanover Psychopharmacology 112, 1-12, 1993 | 200 | 1993 |
| Dependency—Self–Esteem—Clinical Depression RMA Hirschfeld, GL Klerman, P Chodoff, S Korchin, J Barrett Journal of the American Academy of Psychoanalysis 4 (3), 373-388, 1976 | 198 | 1976 |
| Prevalence of mental disorders in primary care. Implications for screening AC Leon, M Olfson, WE Broadhead, JE Barrett, RS Blacklow, MB Keller, ... | 197 | 1995 |
| WAY-163909 [(7bR, 10aR)-1, 2, 3, 4, 8, 9, 10, 10a-octahydro-7bH-cyclopenta-[b][1, 4] diazepino [6, 7, 1hi] indole]: a novel 5-hydroxytryptamine 2C receptor-selective agonist … KL Marquis, AL Sabb, SF Logue, JA Brennan, MJ Piesla, TA Comery, ... Journal of Pharmacology and Experimental Therapeutics 320 (1), 486-496, 2007 | 190 | 2007 |
